Systematic review of evidence to support the theory of psychobiotics

Nutrition Reviews

Volumn 73, Issue 10, 2015, Pages 675-693

  Romijn, Amy R ^a   Rucklidge, Julia J ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

Gut microbiota; Inflammation; Probiotics; Psychobiotics; Psychological outcomes

Indexed keywords

4 AMINOBUTYRIC ACID; PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM INFANTIS; BIFIDOBACTERIUM LONGUM; CENTRAL NERVOUS SYSTEM; COMPULSION; COPING BEHAVIOR; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MENTAL DISEASE; MOOD; MOOD DISORDER; NONHUMAN; PERCEIVED STRESS SCALE; PSYCHOLOGICAL ASPECT; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SOMATIZATION; STREPTOCOCCUS THERMOPHILUS; STRESS; SYSTEMATIC REVIEW; AFFECT; ANXIETY; DOUBLE BLIND PROCEDURE; MENTAL DISORDERS; MENTAL STRESS;

AFFECT; ANXIETY; DOUBLE-BLIND METHOD; GASTROINTESTINAL MICROBIOME; HUMANS; MENTAL DISORDERS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRESS, PSYCHOLOGICAL;

EID: 84947781201     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nuv025     Document Type: Article

References (61)

1. Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III-convergence toward clinical trials. Gut Pathog. 2013;5:4-17. doi:10.1186/1757-4749-5-4.
2. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13:701-712.
3. Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37:137-162.
4. Ezeoke A, Mellor A, Buckley P, et al. A systematic, quantitative review of blood autoantibodies in schizophrenia. Schizophr Res. 2013;150:245-251.
5. Maes M, Kubera M, Obuchowiczwa E, et al. Depression's multiple comorbidities explained by (neuro) inflammatory and oxidative & nitrosative stress pathways. Neuroendocrinol Lett. 2011;32:7-24.
6. Fetissov SO, Dechelotte P. The new link between gut-brain axis and neuropsychiatric disorders. Curr Opin Clin Nutr Metab Care. 2011;14:477-482.
7. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12:453-466.
8. Forsythe P, Sudo N, Dinan T, et al. Mood and gut feelings. Brain Behav Immun. 2010;24:9-16.
9. Sanders ME. Probiotics: definition, sources, selection, and uses. Clin Infect Dis. 2008;46(suppl 2):S58-S61.
10. Arseneault-Breard J, Rondeau I, Gilbert K, et al. Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. Br J Nutr. 2012;107:1793-1799.
11. Desbonnet L, Garrett L, Clarke G, et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010;170:1179-1188.
12. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. 2011;108:16050-16055.
13. Tillisch K, Labus J, Kilpatrick L, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 2013;144:1394-1401.e4.
14. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74:720-726.
15. Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part I-autointoxication revisited. Gut Pathog. 2013;5:5. doi:10.1186/1757-4749-5-5.
16. Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part II-contemporary contextual research. Gut Pathog. 2013;5:3. doi:10.1186/1757-4749-5-3.
17. Logan AC, Katzman M. Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses. 2005;64:533-538.
18. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36:305-312.
19. Thakur AK, Shakya A, Husain GM, et al. Gut-microbiota and mental health: current and future perspectives. J Pharmacol Clin Toxicol. 2014;2:1016-1031.
20. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012;10:735-742.
21. Carpenter S. That gut feeling: exploring the mind-belly-bacteria connection. Monitor Psychol. 2012;43:51-55.
22. Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil. 2011;23:187-192.
23. Dinan TG, Quigley EM. Probiotics in the treatment of depression: science or science fiction? Aust N Z J Psychiatry. 2011;45:1023-1025.
24. Bailey MT, Dowd SE, Galley JD, et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun. 2011;25:397-407.
25. Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013;11:200-216. doi:10.1186/1741-7015-11-200.
26. Maes M, Kubera M, Leunis JC, et al. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand. 2013;127:344-354.
27. Tamboli C, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53:1-4.
28. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9:313-323.
29. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:664-675.
30. Desbonnet L, Garrett L, Clarke G, et al. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008;43:164-174.
31. B receptors in anxiety and depression. Trends Pharmacol Sci. 2005;26:36-43.
32. Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141:599-609.e3.
33. Dickerson FB, Stallings C, Origoni A, et al. Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial. Prim Care Companion CNS Disord. 2014;16. doi:10.4088/PCC.13m01579.
34. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46-56.
35. Maes M, Kubera M, Leunis J-C, et al. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J Affect Disord. 2012;141:55-62.
36. Barrett E, Ross R, O'Toole P, et al. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012;113: 411-417.
37. Rousseaux C, Thuru X, Gelot A, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 2007;13:35-37.
38. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews andmeta-analyses: the PRISMA statement. Ann InternMed. 2009;151:264-269.
39. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
40. Kailasapathy K. Microencapsulation of probiotic bacteria: technology and potential applications. Curr Issues Intest Microbiol. 2002;3:39-48.
41. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2007;61:355-361.
42. Dapoigny M, Piche T, Ducrotte P, et al. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, doubleblind study.World J Gastroenterol. 2012;18:2067-2075.
43. Messaoudi M, Lalonde R, Violle N, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2010;105:755-764.
44. Rao AV, Bested AC, Beaulne TM, et al. A randomized, double-blind, placebocontrolled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009;1:6-12. doi: 10.1186/1757-4749-1-6.
45. Reale M, Boscolo P, Bellante V, et al. Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers. Br J Nutr. 2012;108:308-314.
46. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101:1581-1590.
47. Parracho HM, Gibson GR, Knott F, et al. A double-blind, placebo-controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders. Int J Probiotics Prebiotics. 2010;5:69-74.
48. Vaghef-Mehrabany E, Alipour B, Homayouni-Rad A, et al. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition. 2014;30:430-435.
49. Simrén M, Öhman L, Olsson J, et al. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome-a randomized, double-blind, controlled study. Aliment Pharmacol Ther. 2010;31:218-227.
50. Adams CA. The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev. 2010;23:37-46.
51. Klingberg TD, Budde BB. The survival and persistence in the human gastrointestinal tract of five potential probiotic lactobacilli consumed as freeze-dried cultures or as probiotic sausage. Int J Food Microbiol. 2006;109:157-159.
52. Kidd P. An approach to the nutritional management of autism. Altern Ther Health Med. 2003;9:24-61.
53. Bolte E. Autism and Clostridium tetani. Med Hypotheses. 1998;51:133-144.
54. Finegold SM, Molitoris D, Song Y, et al. Gastrointestinal microflora studies in lateonset autism. Clin Infect Dis. 2002;35(suppl 1):S6-S16.
55. Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol. 2004;70:6459-6465.
56. Parracho HM, Bingham MO, Gibson GR, et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. 2005;54:987-991.
57. d'Eufemia P, Celli M, Finocchiaro R, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996;85:1076-1079.
58. Gondalia SV, Palombo EA, Knowles SR, et al. Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res. 2012;5:419-427.
59. Suvisaari J, Mantere O. Inflammation theories in psychotic disorders: a critical review. Infect Disord Drug Targets. 2013;13:59-70.
60. Messaoudi M, Violle N, Bisson J-F, et al. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes. 2011;2:256-261.
61. Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, et al. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis. 2014;17:519-527.